{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:39:35Z","timestamp":1793381975095,"version":"4.5.0"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T00:00:00Z","timestamp":1471046400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Department of Science and Technology, India","award":["YSS\/2014\/000691"],"award-info":[{"award-number":["YSS\/2014\/000691"]}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","award":["BSC0111"],"award-info":[{"award-number":["BSC0111"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00018-016-2340-9","type":"journal-article","created":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T10:55:15Z","timestamp":1471085715000},"page":"617-629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Expanding role of molecular chaperones in regulating \u03b1-synuclein misfolding; implications in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"74","author":[{"given":"Sandeep K.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3858-9207","authenticated-orcid":false,"given":"Smriti","family":"Priya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,13]]},"reference":[{"key":"2340_CR1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev-biochem-060614-033955","volume":"84","author":"J Labbadia","year":"2015","unstructured":"Labbadia J, Morimoto RI (2015) The biology of proteostasis in aging and disease. Annu Rev Biochem 84:435\u2013464","journal-title":"Annu Rev Biochem"},{"key":"2340_CR2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.1141448","volume":"319","author":"WE Balch","year":"2008","unstructured":"Balch WE, Morimoto RI, Dillin A, Kelly JW (2008) Adapting proteostasis for disease intervention. Science 319:916\u2013919","journal-title":"Science"},{"key":"2340_CR3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tcb.2014.05.003","volume":"24","author":"MS Hipp","year":"2014","unstructured":"Hipp MS, Park SH, Hartl FU (2014) Proteostasis impairment in protein-misfolding and -aggregation diseases. Trends Cell Biol 24:506\u2013514","journal-title":"Trends Cell Biol"},{"key":"2340_CR4","doi-asserted-by":"crossref","first-page":"14914","DOI":"10.1073\/pnas.0902882106","volume":"106","author":"A Ben-Zvi","year":"2009","unstructured":"Ben-Zvi A, Miller EA, Morimoto RI (2009) Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc Natl Acad Sci USA 106:14914\u201314919","journal-title":"Proc Natl Acad Sci USA"},{"key":"2340_CR5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.emboj.7601930","volume":"27","author":"KF Winklhofer","year":"2008","unstructured":"Winklhofer KF, Tatzelt J, Haass C (2008) The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases. EMBO J 27:336\u2013349","journal-title":"EMBO J"},{"issue":"Suppl 1","key":"2340_CR6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","volume":"26","author":"K Wirdefeldt","year":"2011","unstructured":"Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J (2011) Epidemiology and etiology of Parkinson\u2019s disease: a review of the evidence. Eur J Epidemiol 26(Suppl 1):S1\u2013S58","journal-title":"Eur J Epidemiol"},{"issue":"Suppl","key":"2340_CR7","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"CA Ross","year":"2004","unstructured":"Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10(Suppl):S10\u2013S17","journal-title":"Nat Med"},{"key":"2340_CR8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00005072-199804000-00005","volume":"57","author":"MC Irizarry","year":"1998","unstructured":"Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT (1998) Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson\u2019s disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J Neuropathol Exp Neurol 57:334\u2013337","journal-title":"J Neuropathol Exp Neurol"},{"key":"2340_CR9","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469\u20136473","journal-title":"Proc Natl Acad Sci USA"},{"key":"2340_CR10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/1531-8249(200004)47:4<521::AID-ANA18>3.0.CO;2-B","volume":"47","author":"K Wakabayashi","year":"2000","unstructured":"Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H (2000) Synphilin-1 is present in Lewy bodies in Parkinson\u2019s disease. Ann Neurol 47:521\u2013523","journal-title":"Ann Neurol"},{"key":"2340_CR11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF00687787","volume":"75","author":"S Kuzuhara","year":"1988","unstructured":"Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y (1988) Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol 75:345\u2013353","journal-title":"Acta Neuropathol"},{"key":"2340_CR12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0006-8993(00)02702-5","volume":"877","author":"P Shashidharan","year":"2000","unstructured":"Shashidharan P, Good PF, Hsu A, Perl DP, Brin MF, Olanow CW (2000) TorsinA accumulation in Lewy bodies in sporadic Parkinson\u2019s disease. Brain Res 877:379\u2013381","journal-title":"Brain Res"},{"key":"2340_CR13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","volume":"27","author":"K Wakabayashi","year":"2007","unstructured":"Wakabayashi K, Tanji K, Mori F, Takahashi H (2007) The Lewy body in Parkinson\u2019s disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology 27:494\u2013506","journal-title":"Neuropathology"},{"key":"2340_CR14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1474-4422(04)00827-0","volume":"3","author":"CW Olanow","year":"2004","unstructured":"Olanow CW, Perl DP, DeMartino GN, McNaught KS (2004) Lewy-body formation is an aggresome-related process: a hypothesis. Lancet Neurol 3:496\u2013503","journal-title":"Lancet Neurol"},{"key":"2340_CR15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/jnnp.74.2.158","volume":"74","author":"DT Wade","year":"2003","unstructured":"Wade DT, Gage H, Owen C, Trend P, Grossmith C, Kaye J (2003) Multidisciplinary rehabilitation for people with Parkinson\u2019s disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 74:158\u2013162","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2340_CR16","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"2340_CR17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18:106\u2013108","journal-title":"Nat Genet"},{"key":"2340_CR18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164\u2013173","journal-title":"Ann Neurol"},{"key":"2340_CR19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605\u2013608","journal-title":"Nature"},{"key":"2340_CR20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"V Bonifati","year":"2003","unstructured":"Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256\u2013259","journal-title":"Science"},{"key":"2340_CR21","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW (2004) Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304:1158\u20131160","journal-title":"Science"},{"key":"2340_CR22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0070-2153(06)76003-3","volume":"76","author":"A Williams","year":"2006","unstructured":"Williams A, Jahreiss L, Sarkar S, Saiki S, Menzies FM, Ravikumar B, Rubinsztein DC (2006) Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications. Curr Top Dev Biol 76:89\u2013101","journal-title":"Curr Top Dev Biol"},{"key":"2340_CR23","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","volume":"38","author":"A Ramirez","year":"2006","unstructured":"Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, Cid LP, Goebel I, Mubaidin AF, Wriekat AL, Roeper J, Al-Din A, Hillmer AM, Karsak M, Liss B, Woods CG, Behrens MI, Kubisch C (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38:1184\u20131191","journal-title":"Nat Genet"},{"key":"2340_CR24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Paisan-Ruiz","year":"2004","unstructured":"Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez de Munain A, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, Carrera IM, Pena AS, de Silva R, Lees A, Marti-Masso JF, Perez-Tur J, Wood NW, Singleton AB (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron 44:595\u2013600","journal-title":"Neuron"},{"key":"2340_CR25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Muller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601\u2013607","journal-title":"Neuron"},{"key":"2340_CR26","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1523\/JNEUROSCI.4564-06.2007","volume":"27","author":"ML Kramer","year":"2007","unstructured":"Kramer ML, Schulz-Schaeffer WJ (2007) Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 27:1405\u20131410","journal-title":"J Neurosci"},{"key":"2340_CR27","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner B, Jappelli R, Maji SK, Desplats PA, Boyer L, Aigner S, Hetzer C, Loher T, Vilar M, Campioni S, Tzitzilonis C, Soragni A, Jessberger S, Mira H, Consiglio A, Pham E, Masliah E, Gage FH, Riek R (2011) In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci USA 108:4194\u20134199","journal-title":"Proc Natl Acad Sci USA"},{"key":"2340_CR28","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","volume":"20","author":"DD Murphy","year":"2000","unstructured":"Murphy DD, Rueter SM, Trojanowski JQ, Lee VM (2000) Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 20:3214\u20133220","journal-title":"J Neurosci"},{"key":"2340_CR29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1074\/jbc.M107045200","volume":"277","author":"HJ Lee","year":"2002","unstructured":"Lee HJ, Choi C, Lee SJ (2002) Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J Biol Chem 277:671\u2013678","journal-title":"J Biol Chem"},{"key":"2340_CR30","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1074\/jbc.275.12.8812","volume":"275","author":"PJ McLean","year":"2000","unstructured":"McLean PJ, Kawamata H, Ribich S, Hyman BT (2000) Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson\u2019s disease-linked mutations. J Biol Chem 275:8812\u20138816","journal-title":"J Biol Chem"},{"key":"2340_CR31","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1021\/bi030086j","volume":"42","author":"MJ Volles","year":"2003","unstructured":"Volles MJ, Lansbury PT Jr (2003) Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson\u2019s disease. Biochemistry 42:7871\u20137878","journal-title":"Biochemistry"},{"key":"2340_CR32","doi-asserted-by":"crossref","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","volume":"274","author":"SJ Wood","year":"1999","unstructured":"Wood SJ, Wypych J, Steavenson S, Louis JC, Citron M, Biere AL (1999) alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson\u2019s disease. J Biol Chem 274:19509\u201319512","journal-title":"J Biol Chem"},{"key":"2340_CR33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E (2013) The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 14:38\u201348","journal-title":"Nat Rev Neurosci"},{"key":"2340_CR34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/jnc.12226","volume":"125","author":"S Schildknecht","year":"2013","unstructured":"Schildknecht S, Gerding HR, Karreman C, Drescher M, Lashuel HA, Outeiro TF, Di Monte DA, Leist M (2013) Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies. J Neurochem 125:491\u2013511","journal-title":"J Neurochem"},{"key":"2340_CR35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb841","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164","journal-title":"Nat Cell Biol"},{"key":"2340_CR36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/187152710791556140","volume":"9","author":"N Cavallarin","year":"2010","unstructured":"Cavallarin N, Vicario M, Negro A (2010) The role of phosphorylation in synucleinopathies: focus on Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 9:471\u2013481","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2340_CR37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mcn.2014.08.002","volume":"62","author":"R Perfeito","year":"2014","unstructured":"Perfeito R, Lazaro DF, Outeiro TF, Rego AC (2014) Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells. Mol Cell Neurosci 62:51\u201359","journal-title":"Mol Cell Neurosci"},{"key":"2340_CR38","first-page":"777","volume":"118","author":"M Martinez-Vicente","year":"2008","unstructured":"Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV, Hodara R, Fredenburg R, Wu DC, Follenzi A, Dauer W, Przedborski S, Ischiropoulos H, Lansbury PT, Sulzer D, Cuervo AM (2008) Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest 118:777\u2013788","journal-title":"J Clin Invest"},{"key":"2340_CR39","doi-asserted-by":"crossref","first-page":"e5515","DOI":"10.1371\/journal.pone.0005515","volume":"4","author":"M Xilouri","year":"2009","unstructured":"Xilouri M, Vogiatzi T, Vekrellis K, Park D, Stefanis L (2009) Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS One 4:e5515","journal-title":"PLoS One"},{"key":"2340_CR40","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(11)70213-7","volume":"10","author":"K Vekrellis","year":"2011","unstructured":"Vekrellis K, Xilouri M, Emmanouilidou E, Rideout HJ, Stefanis L (2011) Pathological roles of alpha-synuclein in neurological disorders. Lancet Neurol 10:1015\u20131025","journal-title":"Lancet Neurol"},{"key":"2340_CR41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(14)61010-2","volume":"384","author":"AH Schapira","year":"2014","unstructured":"Schapira AH, Olanow CW, Greenamyre JT, Bezard E (2014) Slowing of neurodegeneration in Parkinson\u2019s disease and Huntington\u2019s disease: future therapeutic perspectives. Lancet 384:545\u2013555","journal-title":"Lancet"},{"key":"2340_CR42","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1146\/annurev.biochem.052308.114844","volume":"78","author":"ET Powers","year":"2009","unstructured":"Powers ET, Morimoto RI, Dillin A, Kelly JW, Balch WE (2009) Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 78:959\u2013991","journal-title":"Annu Rev Biochem"},{"key":"2340_CR43","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1007\/s00018-014-1627-y","volume":"71","author":"RU Mattoo","year":"2014","unstructured":"Mattoo RU, Goloubinoff P (2014) Molecular chaperones are nanomachines that catalytically unfold misfolded and alternatively folded proteins. Cell Mol Life Sci 71:3311\u20133325","journal-title":"Cell Mol Life Sci"},{"key":"2340_CR44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.181.4096.223","volume":"181","author":"CB Anfinsen","year":"1973","unstructured":"Anfinsen CB (1973) Principles that govern the folding of protein chains. Science 181:223\u2013230","journal-title":"Science"},{"key":"2340_CR45","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1126\/science.7886447","volume":"267","author":"PG Wolynes","year":"1995","unstructured":"Wolynes PG, Onuchic JN, Thirumalai D (1995) Navigating the folding routes. Science 267:1619\u20131620","journal-title":"Science"},{"key":"2340_CR46","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1126\/science.1068408","volume":"295","author":"FU Hartl","year":"2002","unstructured":"Hartl FU, Hayer-Hartl M (2002) Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295:1852\u20131858","journal-title":"Science"},{"key":"2340_CR47","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1146\/annurev.biochem.70.1.603","volume":"70","author":"J Frydman","year":"2001","unstructured":"Frydman J (2001) Folding of newly translated proteins in vivo: the role of molecular chaperones. Annu Rev Biochem 70:603\u2013647","journal-title":"Annu Rev Biochem"},{"key":"2340_CR48","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1146\/annurev.ge.22.120188.003215","volume":"22","author":"S Lindquist","year":"1988","unstructured":"Lindquist S, Craig EA (1988) The heat-shock proteins. Annu Rev Genet 22:631\u2013677","journal-title":"Annu Rev Genet"},{"key":"2340_CR49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12192-010-0216-8","volume":"16","author":"A Finka","year":"2011","unstructured":"Finka A, Mattoo RU, Goloubinoff P (2011) Meta-analysis of heat- and chemically upregulated chaperone genes in plant and human cells. Cell Stress Chaperones 16:15\u201331","journal-title":"Cell Stress Chaperones"},{"key":"2340_CR50","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1126\/science.3798113","volume":"235","author":"R Elber","year":"1987","unstructured":"Elber R, Karplus M (1987) Multiple conformational states of proteins: a molecular dynamics analysis of myoglobin. Science 235:318\u2013321","journal-title":"Science"},{"key":"2340_CR51","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jmb.2012.12.025","volume":"425","author":"A Natalello","year":"2013","unstructured":"Natalello A, Mattoo RU, Priya S, Sharma SK, Goloubinoff P, Doglia SM (2013) Biophysical characterization of two different stable misfolded monomeric polypeptides that are chaperone-amenable substrates. J Mol Biol 425:1158\u20131171","journal-title":"J Mol Biol"},{"key":"2340_CR52","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nchembio.791","volume":"8","author":"Rios P Los De","year":"2012","unstructured":"De Los Rios P, Goloubinoff P (2012) Protein folding: chaperoning protein evolution. Nat Chem Biol 8:226\u2013228","journal-title":"Nat Chem Biol"},{"key":"2340_CR53","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/418291a","volume":"418","author":"HA Lashuel","year":"2002","unstructured":"Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PT Jr (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418:291","journal-title":"Nature"},{"key":"2340_CR54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/355033a0","volume":"355","author":"MJ Gething","year":"1992","unstructured":"Gething MJ, Sambrook J (1992) Protein folding in the cell. Nature 355:33\u201345","journal-title":"Nature"},{"key":"2340_CR55","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cell.2006.04.014","volume":"125","author":"B Bukau","year":"2006","unstructured":"Bukau B, Weissman J, Horwich A (2006) Molecular chaperones and protein quality control. Cell 125:443\u2013451","journal-title":"Cell"},{"key":"2340_CR56","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature10317","volume":"475","author":"FU Hartl","year":"2011","unstructured":"Hartl FU, Bracher A, Hayer-Hartl M (2011) Molecular chaperones in protein folding and proteostasis. Nature 475:324\u2013332","journal-title":"Nature"},{"key":"2340_CR57","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrm2993","volume":"11","author":"J Tyedmers","year":"2010","unstructured":"Tyedmers J, Mogk A, Bukau B (2010) Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol 11:777\u2013788","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2340_CR58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nsmb1046","volume":"13","author":"NA Ranson","year":"2006","unstructured":"Ranson NA, Clare DK, Farr GW, Houldershaw D, Horwich AL, Saibil HR (2006) Allosteric signaling of ATP hydrolysis in GroEL-GroES complexes. Nat Struct Mol Biol 13:147\u2013152","journal-title":"Nat Struct Mol Biol"},{"key":"2340_CR59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2010.05.007","volume":"40","author":"C Voisine","year":"2010","unstructured":"Voisine C, Pedersen JS, Morimoto RI (2010) Chaperone networks: tipping the balance in protein folding diseases. Neurobiol Dis 40:12\u201320","journal-title":"Neurobiol Dis"},{"key":"2340_CR60","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1385\/JMN:30:3:249","volume":"30","author":"MP Hinault","year":"2006","unstructured":"Hinault MP, Ben-Zvi A, Goloubinoff P (2006) Chaperones and proteases: cellular fold-controlling factors of proteins in neurodegenerative diseases and aging. J Mol Neurosci 30:249\u2013265","journal-title":"J Mol Neurosci"},{"key":"2340_CR61","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.febslet.2013.05.014","volume":"587","author":"S Priya","year":"2013","unstructured":"Priya S, Sharma SK, Goloubinoff P (2013) Molecular chaperones as enzymes that catalytically unfold misfolded polypeptides. FEBS Lett 587:1981\u20131987","journal-title":"FEBS Lett"},{"key":"2340_CR62","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1073\/pnas.1219867110","volume":"110","author":"S Priya","year":"2013","unstructured":"Priya S, Sharma SK, Sood V, Mattoo RU, Finka A, Azem A, De Los Rios P, Goloubinoff P (2013) GroEL and CCT are catalytic unfoldases mediating out-of-cage polypeptide refolding without ATP. Proc Natl Acad Sci USA 110:7199\u20137204","journal-title":"Proc Natl Acad Sci USA"},{"key":"2340_CR63","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1471-4159.2002.01190.x","volume":"83","author":"PJ McLean","year":"2002","unstructured":"McLean PJ, Kawamata H, Shariff S, Hewett J, Sharma N, Ueda K, Breakefield XO, Hyman BT (2002) TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation. J Neurochem 83:846\u2013854","journal-title":"J Neurochem"},{"key":"2340_CR64","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JPD-2011-11044","volume":"1","author":"D Ebrahimi-Fakhari","year":"2011","unstructured":"Ebrahimi-Fakhari D, Wahlster L, McLean PJ (2011) Molecular chaperones in Parkinson\u2019s disease\u2013present and future. J Parkinsons Dis 1:299\u2013320","journal-title":"J Parkinsons Dis"},{"key":"2340_CR65","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jmb.2005.06.060","volume":"351","author":"TR Flower","year":"2005","unstructured":"Flower TR, Chesnokova LS, Froelich CA, Dixon C, Witt SN (2005) Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson\u2019s disease. J Mol Biol 351:1081\u20131100","journal-title":"J Mol Biol"},{"key":"2340_CR66","doi-asserted-by":"crossref","first-page":"25497","DOI":"10.1074\/jbc.M400255200","volume":"279","author":"J Klucken","year":"2004","unstructured":"Klucken J, Shin Y, Masliah E, Hyman BT, McLean PJ (2004) Hsp70 reduces alpha-synuclein aggregation and toxicity. J Biol Chem 279:25497\u201325502","journal-title":"J Biol Chem"},{"key":"2340_CR67","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nm1102-1185","volume":"8","author":"PK Auluck","year":"2002","unstructured":"Auluck PK, Bonini NM (2002) Pharmacological prevention of Parkinson disease in Drosophila. Nat Med 8:1185\u20131186","journal-title":"Nat Med"},{"key":"2340_CR68","doi-asserted-by":"crossref","first-page":"39155","DOI":"10.1074\/jbc.M405456200","volume":"279","author":"Y Zhou","year":"2004","unstructured":"Zhou Y, Gu G, Goodlett DR, Zhang T, Pan C, Montine TJ, Montine KS, Aebersold RH, Zhang J (2004) Analysis of alpha-synuclein-associated proteins by quantitative proteomics. J Biol Chem 279:39155\u201339164","journal-title":"J Biol Chem"},{"key":"2340_CR69","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.1074\/jbc.M413024200","volume":"280","author":"MM Dedmon","year":"2005","unstructured":"Dedmon MM, Christodoulou J, Wilson MR, Dobson CM (2005) Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species. J Biol Chem 280:14733\u201314740","journal-title":"J Biol Chem"},{"key":"2340_CR70","doi-asserted-by":"crossref","first-page":"38173","DOI":"10.1074\/jbc.M110.127753","volume":"285","author":"MP Hinault","year":"2010","unstructured":"Hinault MP, Cuendet AF, Mattoo RU, Mensi M, Dietler G, Lashuel HA, Goloubinoff P (2010) Stable alpha-synuclein oligomers strongly inhibit chaperone activity of the Hsp70 system by weak interactions with J-domain co-chaperones. J Biol Chem 285:38173\u201338182","journal-title":"J Biol Chem"},{"key":"2340_CR71","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s12192-013-0413-3","volume":"18","author":"A Finka","year":"2013","unstructured":"Finka A, Goloubinoff P (2013) Proteomic data from human cell cultures refine mechanisms of chaperone-mediated protein homeostasis. Cell Stress Chaperones 18:591\u2013605","journal-title":"Cell Stress Chaperones"},{"key":"2340_CR72","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00401-005-0027-7","volume":"111","author":"J Klucken","year":"2006","unstructured":"Klucken J, Ingelsson M, Shin Y, Irizarry MC, Hedley-Whyte ET, Frosch M, Growdon J, McLean P, Hyman BT (2006) Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies. Acta Neuropathol 111:101\u2013108","journal-title":"Acta Neuropathol"},{"key":"2340_CR73","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/jnen\/62.6.644","volume":"62","author":"Y Saito","year":"2003","unstructured":"Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, Arai T, Nagura H, Yamanouchi H, Hasegawa M, Iwatsubo T, Murayama S (2003) Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 62:644\u2013654","journal-title":"J Neuropathol Exp Neurol"},{"key":"2340_CR74","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nchembio.455","volume":"6","author":"SK Sharma","year":"2010","unstructured":"Sharma SK, De los Rios P, Christen P, Lustig A, Goloubinoff P (2010) The kinetic parameters and energy cost of the Hsp70 chaperone as a polypeptide unfoldase. Nat Chem Biol 6:914\u2013920","journal-title":"Nat Chem Biol"},{"key":"2340_CR75","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2174\/138920309789351930","volume":"10","author":"SK Sharma","year":"2009","unstructured":"Sharma SK, Christen P, Goloubinoff P (2009) Disaggregating chaperones: an unfolding story. Curr Protein Pept Sci 10:432\u2013446","journal-title":"Curr Protein Pept Sci"},{"key":"2340_CR76","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrm2941","volume":"11","author":"HH Kampinga","year":"2010","unstructured":"Kampinga HH, Craig EA (2010) The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nat Rev Mol Cell Biol 11:579\u2013592","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2340_CR77","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/brain\/aws022","volume":"135","author":"J Labbadia","year":"2012","unstructured":"Labbadia J, Novoselov SS, Bett JS, Weiss A, Paganetti P, Bates GP, Cheetham ME (2012) Suppression of protein aggregation by chaperone modification of high molecular weight complexes. Brain 135:1180\u20131196","journal-title":"Brain"},{"key":"2340_CR78","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1096\/fj.10-164624","volume":"25","author":"KM Danzer","year":"2011","unstructured":"Danzer KM, Ruf WP, Putcha P, Joyner D, Hashimoto T, Glabe C, Hyman BT, McLean PJ (2011) Heat-shock protein 70 modulates toxic extracellular alpha-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J 25:326\u2013336","journal-title":"FASEB J"},{"key":"2340_CR79","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbrc.2004.07.021","volume":"321","author":"PJ McLean","year":"2004","unstructured":"McLean PJ, Klucken J, Shin Y, Hyman BT (2004) Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro. Biochem Biophys Res Commun 321:665\u2013669","journal-title":"Biochem Biophys Res Commun"},{"key":"2340_CR80","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1073\/pnas.0710531105","volume":"105","author":"JC Opazo","year":"2008","unstructured":"Opazo JC, Hoffmann FG, Storz JF (2008) Genomic evidence for independent origins of beta-like globin genes in monotremes and therian mammals. Proc Natl Acad Sci USA 105:1590\u20131595","journal-title":"Proc Natl Acad Sci USA"},{"key":"2340_CR81","doi-asserted-by":"crossref","first-page":"e1867","DOI":"10.1371\/journal.pone.0001867","volume":"3","author":"TF Outeiro","year":"2008","unstructured":"Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F, Hyman BT, McLean PJ (2008) Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS One 3:e1867","journal-title":"PLoS One"},{"key":"2340_CR82","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.1074\/jbc.M306390200","volume":"279","author":"E Lindersson","year":"2004","unstructured":"Lindersson E, Beedholm R, Hojrup P, Moos T, Gai W, Hendil KB, Jensen PH (2004) Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem 279:12924\u201312934","journal-title":"J Biol Chem"},{"key":"2340_CR83","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/emboj.2009.298","volume":"28","author":"C Roodveldt","year":"2009","unstructured":"Roodveldt C, Bertoncini CW, Andersson A, van der Goot AT, Hsu ST, Fernandez-Montesinos R, de Jong J, van Ham TJ, Nollen EA, Pozo D, Christodoulou J, Dobson CM (2009) Chaperone proteostasis in Parkinson\u2019s disease: stabilization of the Hsp70\/alpha-synuclein complex by Hip. EMBO J 28:3758\u20133770","journal-title":"EMBO J"},{"key":"2340_CR84","doi-asserted-by":"crossref","first-page":"12614","DOI":"10.1021\/bi801475r","volume":"47","author":"KC Luk","year":"2008","unstructured":"Luk KC, Mills IP, Trojanowski JQ, Lee VM (2008) Interactions between Hsp70 and the hydrophobic core of alpha-synuclein inhibit fibril assembly. Biochemistry 47:12614\u201312625","journal-title":"Biochemistry"},{"key":"2340_CR85","doi-asserted-by":"crossref","first-page":"e1977","DOI":"10.1038\/cddis.2015.336","volume":"6","author":"MM Yurinskaya","year":"2015","unstructured":"Yurinskaya MM, Mitkevich VA, Kozin SA, Evgen\u2019ev MB, Makarov AA, Vinokurov MG (2015) HSP70 protects human neuroblastoma cells from apoptosis and oxidative stress induced by amyloid peptide isoAsp7-Abeta(1-42). Cell Death Dis 6:e1977","journal-title":"Cell Death Dis"},{"key":"2340_CR86","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fmolb.2015.00029","volume":"2","author":"A Finka","year":"2015","unstructured":"Finka A, Sharma SK, Goloubinoff P (2015) Multi-layered molecular mechanisms of polypeptide holding, unfolding and disaggregation by HSP70\/HSP110 chaperones. Front Mol Biosci 2:29","journal-title":"Front Mol Biosci"},{"key":"2340_CR87","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/jpet.109.158436","volume":"332","author":"P Putcha","year":"2010","unstructured":"Putcha P, Danzer KM, Kranich LR, Scott A, Silinski M, Mabbett S, Hicks CD, Veal JM, Steed PM, Hyman BT, McLean PJ (2010) Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity. J Pharmacol Exp Ther 332:849\u2013857","journal-title":"J Pharmacol Exp Ther"},{"key":"2340_CR88","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1021\/cb400017h","volume":"8","author":"K Kilpatrick","year":"2013","unstructured":"Kilpatrick K, Novoa JA, Hancock T, Guerriero CJ, Wipf P, Brodsky JL, Segatori L (2013) Chemical induction of Hsp70 reduces alpha-synuclein aggregation in neuroglioma cells. ACS Chem Biol 8:1460\u20131468","journal-title":"ACS Chem Biol"},{"key":"2340_CR89","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molcel.2010.01.001","volume":"37","author":"J Hageman","year":"2010","unstructured":"Hageman J, Rujano MA, van Waarde MA, Kakkar V, Dirks RP, Govorukhina N, Oosterveld-Hut HM, Lubsen NH, Kampinga HH (2010) A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation. Mol Cell 37:355\u2013369","journal-title":"Mol Cell"},{"issue":"Pt 2","key":"2340_CR90","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1042\/bj2840469","volume":"284","author":"ME Cheetham","year":"1992","unstructured":"Cheetham ME, Brion JP, Anderton BH (1992) Human homologues of the bacterial heat-shock protein DnaJ are preferentially expressed in neurons. Biochem J 284(Pt 2):469\u2013476","journal-title":"Biochem J"},{"key":"2340_CR91","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.molcel.2015.07.012","volume":"59","author":"X Gao","year":"2015","unstructured":"Gao X, Carroni M, Nussbaum-Krammer C, Mogk A, Nillegoda NB, Szlachcic A, Guilbride DL, Saibil HR, Mayer MP, Bukau B (2015) Human Hsp70 disaggregase reverses Parkinson\u2019s-linked alpha-synuclein amyloid fibrils. Mol Cell 59:781\u2013793","journal-title":"Mol Cell"},{"key":"2340_CR92","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cell.2008.05.022","volume":"133","author":"S Polier","year":"2008","unstructured":"Polier S, Dragovic Z, Hartl FU, Bracher A (2008) Structural basis for the cooperation of Hsp70 and Hsp110 chaperones in protein folding. Cell 133:1068\u20131079","journal-title":"Cell"},{"key":"2340_CR93","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1038\/emboj.2012.264","volume":"31","author":"H Rampelt","year":"2012","unstructured":"Rampelt H, Kirstein-Miles J, Nillegoda NB, Chi K, Scholz SR, Morimoto RI, Bukau B (2012) Metazoan Hsp70 machines use Hsp110 to power protein disaggregation. EMBO J 31:4221\u20134235","journal-title":"EMBO J"},{"key":"2340_CR94","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.yexcr.2010.06.003","volume":"316","author":"N Yamagishi","year":"2010","unstructured":"Yamagishi N, Goto K, Nakagawa S, Saito Y, Hatayama T (2010) Hsp105 reduces the protein aggregation and cytotoxicity by expanded-polyglutamine proteins through the induction of Hsp70. Exp Cell Res 316:2424\u20132433","journal-title":"Exp Cell Res"},{"key":"2340_CR95","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12192-016-0678-4","volume":"21","author":"T Zininga","year":"2016","unstructured":"Zininga T, Achilonu I, Hoppe H, Prinsloo E, Dirr HW, Shonhai A (2016) Plasmodium falciparum Hsp70-z, an Hsp110 homologue, exhibits independent chaperone activity and interacts with Hsp70-1 in a nucleotide-dependent fashion. Cell Stress Chaperones 21:499\u2013513","journal-title":"Cell Stress Chaperones"},{"key":"2340_CR96","doi-asserted-by":"crossref","first-page":"21399","DOI":"10.1074\/jbc.M113.479253","volume":"288","author":"RU Mattoo","year":"2013","unstructured":"Mattoo RU, Sharma SK, Priya S, Finka A, Goloubinoff P (2013) Hsp110 is a bona fide chaperone using ATP to unfold stable misfolded polypeptides and reciprocally collaborate with Hsp70 to solubilize protein aggregates. J Biol Chem 288:21399\u201321411","journal-title":"J Biol Chem"},{"key":"2340_CR97","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmolb.2014.00007","volume":"1","author":"RU Mattoo","year":"2014","unstructured":"Mattoo RU, Farina Henriquez Cuendet A, Subanna S, Finka A, Priya S, Sharma SK, Goloubinoff P (2014) Synergism between a foldase and an unfoldase: reciprocal dependence between the thioredoxin-like activity of DnaJ and the polypeptide-unfolding activity of DnaK. Front Mol Biosci 1:7","journal-title":"Front Mol Biosci"},{"key":"2340_CR98","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tibs.2008.09.010","volume":"34","author":"SM Doyle","year":"2009","unstructured":"Doyle SM, Wickner S (2009) Hsp104 and ClpB: protein disaggregating machines. Trends Biochem Sci 34:40\u201348","journal-title":"Trends Biochem Sci"},{"key":"2340_CR99","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1172\/JCI35781","volume":"118","author":"C Lo Bianco","year":"2008","unstructured":"Lo Bianco C, Shorter J, Regulier E, Lashuel H, Iwatsubo T, Lindquist S, Aebischer P (2008) Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease. J Clin Invest 118:3087\u20133097","journal-title":"J Clin Invest"},{"key":"2340_CR100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fmolb.2015.00022","volume":"2","author":"A Mogk","year":"2015","unstructured":"Mogk A, Kummer E, Bukau B (2015) Cooperation of Hsp70 and Hsp100 chaperone machines in protein disaggregation. Front Mol Biosci 2:22","journal-title":"Front Mol Biosci"},{"key":"2340_CR101","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1126\/science.2188365","volume":"248","author":"Y Sanchez","year":"1990","unstructured":"Sanchez Y, Lindquist SL (1990) HSP104 required for induced thermotolerance. Science 248:1112\u20131115","journal-title":"Science"},{"key":"2340_CR102","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(00)81223-4","volume":"94","author":"JR Glover","year":"1998","unstructured":"Glover JR, Lindquist S (1998) Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell 94:73\u201382","journal-title":"Cell"},{"key":"2340_CR103","doi-asserted-by":"crossref","first-page":"8107","DOI":"10.1021\/bi0493766","volume":"43","author":"DD Mosser","year":"2004","unstructured":"Mosser DD, Ho S, Glover JR (2004) Saccharomyces cerevisiae Hsp104 enhances the chaperone capacity of human cells and inhibits heat stress-induced proapoptotic signaling. Biochemistry 43:8107\u20138115","journal-title":"Biochemistry"},{"key":"2340_CR104","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1126\/science.1098007","volume":"304","author":"J Shorter","year":"2004","unstructured":"Shorter J, Lindquist S (2004) Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 304:1793\u20131797","journal-title":"Science"},{"key":"2340_CR105","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jmb.2008.09.063","volume":"384","author":"M Arimon","year":"2008","unstructured":"Arimon M, Grimminger V, Sanz F, Lashuel HA (2008) Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Abeta fibrils and protofibrils. J Mol Biol 384:1157\u20131173","journal-title":"J Mol Biol"},{"key":"2340_CR106","first-page":"e3190","volume":"55","author":"EA Sweeny","year":"2011","unstructured":"Sweeny EA, DeSantis ME, Shorter J (2011) Purification of hsp104, a protein disaggregase. J Vis Exp 55:e3190","journal-title":"J Vis Exp"},{"key":"2340_CR107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/O09-121","volume":"88","author":"S Vashist","year":"2010","unstructured":"Vashist S, Cushman M, Shorter J (2010) Applying Hsp104 to protein-misfolding disorders. Biochem Cell Biol 88:1\u201313","journal-title":"Biochem Cell Biol"},{"key":"2340_CR108","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cell.2012.09.038","volume":"151","author":"ME DeSantis","year":"2012","unstructured":"DeSantis ME, Leung EH, Sweeny EA, Jackrel ME, Cushman-Nick M, Neuhaus-Follini A, Vashist S, Sochor MA, Knight MN, Shorter J (2012) Operational plasticity enables hsp104 to disaggregate diverse amyloid and nonamyloid clients. Cell 151:778\u2013793","journal-title":"Cell"},{"key":"2340_CR109","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cell.2013.11.047","volume":"156","author":"ME Jackrel","year":"2014","unstructured":"Jackrel ME, DeSantis ME, Martinez BA, Castellano LM, Stewart RM, Caldwell KA, Caldwell GA, Shorter J (2014) Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events. Cell 156:170\u2013182","journal-title":"Cell"},{"key":"2340_CR110","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1126\/science.1124646","volume":"313","author":"E Cohen","year":"2006","unstructured":"Cohen E, Bieschke J, Perciavalle RM, Kelly JW, Dillin A (2006) Opposing activities protect against age-onset proteotoxicity. Science 313:1604\u20131610","journal-title":"Science"},{"key":"2340_CR111","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(02)02777-1","volume":"520","author":"S Thoms","year":"2002","unstructured":"Thoms S (2002) Cdc48 can distinguish between native and non-native proteins in the absence of cofactors. FEBS Lett 520:107\u2013110","journal-title":"FEBS Lett"},{"key":"2340_CR112","doi-asserted-by":"crossref","first-page":"13732","DOI":"10.1073\/pnas.96.24.13732","volume":"96","author":"P Goloubinoff","year":"1999","unstructured":"Goloubinoff P, Mogk A, Zvi AP, Tomoyasu T, Bukau B (1999) Sequential mechanism of solubilization and refolding of stable protein aggregates by a bichaperone network. Proc Natl Acad Sci USA 96:13732\u201313737","journal-title":"Proc Natl Acad Sci USA"},{"key":"2340_CR113","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tibs.2011.11.005","volume":"37","author":"E Basha","year":"2012","unstructured":"Basha E, O\u2019Neill H, Vierling E (2012) Small heat shock proteins and alpha-crystallins: dynamic proteins with flexible functions. Trends Biochem Sci 37:106\u2013117","journal-title":"Trends Biochem Sci"},{"key":"2340_CR114","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1021\/bi900212j","volume":"48","author":"HS McHaourab","year":"2009","unstructured":"McHaourab HS, Godar JA, Stewart PL (2009) Structure and mechanism of protein stability sensors: chaperone activity of small heat shock proteins. Biochemistry 48:3828\u20133837","journal-title":"Biochemistry"},{"key":"2340_CR115","doi-asserted-by":"crossref","first-page":"11032","DOI":"10.1074\/jbc.273.18.11032","volume":"273","author":"L Veinger","year":"1998","unstructured":"Veinger L, Diamant S, Buchner J, Goloubinoff P (1998) The small heat-shock protein IbpB from Escherichia coli stabilizes stress-denatured proteins for subsequent refolding by a multichaperone network. J Biol Chem 273:11032\u201311037","journal-title":"J Biol Chem"},{"key":"2340_CR116","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.neuroscience.2008.01.058","volume":"153","author":"S Quraishe","year":"2008","unstructured":"Quraishe S, Asuni A, Boelens WC, O\u2019Connor V, Wyttenbach A (2008) Expression of the small heat shock protein family in the mouse CNS: differential anatomical and biochemical compartmentalization. Neuroscience 153:483\u2013491","journal-title":"Neuroscience"},{"key":"2340_CR117","doi-asserted-by":"crossref","first-page":"10449","DOI":"10.1073\/pnas.89.21.10449","volume":"89","author":"J Horwitz","year":"1992","unstructured":"Horwitz J (1992) Alpha-crystallin can function as a molecular chaperone. Proc Natl Acad Sci USA 89:10449\u201310453","journal-title":"Proc Natl Acad Sci USA"},{"key":"2340_CR118","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.biocel.2012.02.015","volume":"44","author":"AR Clark","year":"2012","unstructured":"Clark AR, Lubsen NH, Slingsby C (2012) sHSP in the eye lens: crystallin mutations, cataract and proteostasis. Int J Biochem Cell Biol 44:1687\u20131697","journal-title":"Int J Biochem Cell Biol"},{"key":"2340_CR119","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbapap.2014.12.019","volume":"1854","author":"R Bakthisaran","year":"2015","unstructured":"Bakthisaran R, Tangirala R, Rao ChM (2015) Small heat shock proteins: role in cellular functions and pathology. Biochim Biophys Acta 1854:291\u2013319","journal-title":"Biochim Biophys Acta"},{"key":"2340_CR120","doi-asserted-by":"crossref","first-page":"9439","DOI":"10.1073\/pnas.152313999","volume":"99","author":"V Fonte","year":"2002","unstructured":"Fonte V, Kapulkin WJ, Taft A, Fluet A, Friedman D, Link CD (2002) Interaction of intracellular beta amyloid peptide with chaperone proteins. Proc Natl Acad Sci USA 99:9439\u20139444","journal-title":"Proc Natl Acad Sci USA"},{"key":"2340_CR121","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbrc.2006.10.085","volume":"351","author":"TF Outeiro","year":"2006","unstructured":"Outeiro TF, Klucken J, Strathearn KE, Liu F, Nguyen P, Rochet JC, Hyman BT, McLean PJ (2006) Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation. Biochem Biophys Res Commun 351:631\u2013638","journal-title":"Biochem Biophys Res Commun"},{"key":"2340_CR122","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jmb.2004.05.054","volume":"340","author":"A Rekas","year":"2004","unstructured":"Rekas A, Adda CG, Andrew Aquilina J, Barnham KJ, Sunde M, Galatis D, Williamson NA, Masters CL, Anders RF, Robinson CV, Cappai R, Carver JA (2004) Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity. J Mol Biol 340:1167\u20131183","journal-title":"J Mol Biol"},{"key":"2340_CR123","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bpj.2009.10.056","volume":"98","author":"CA Waudby","year":"2010","unstructured":"Waudby CA, Knowles TP, Devlin GL, Skepper JN, Ecroyd H, Carver JA, Welland ME, Christodoulou J, Dobson CM, Meehan S (2010) The interaction of alphaB-crystallin with mature alpha-synuclein amyloid fibrils inhibits their elongation. Biophys J 98:843\u2013851","journal-title":"Biophys J"},{"key":"2340_CR124","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.brainres.2006.03.058","volume":"1089","author":"MM Wilhelmus","year":"2006","unstructured":"Wilhelmus MM, Boelens WC, Otte-Holler I, Kamps B, de Waal RM, Verbeek MM (2006) Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity. Brain Res 1089:67\u201378","journal-title":"Brain Res"},{"key":"2340_CR125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.30195","volume":"137B","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, James M, Middleton FA, Davis RL (2005) Transcriptional analysis of multiple brain regions in Parkinson\u2019s disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet 137B:5\u201316","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"2340_CR126","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/bbrc.1999.1167","volume":"262","author":"GJ Stege","year":"1999","unstructured":"Stege GJ, Renkawek K, Overkamp PS, Verschuure P, van Rijk AF, Reijnen-Aalbers A, Boelens WC, Bosman GJ, de Jong WW (1999) The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity. Biochem Biophys Res Commun 262:152\u2013156","journal-title":"Biochem Biophys Res Commun"},{"key":"2340_CR127","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-5793(97)01180-0","volume":"416","author":"YC Kudva","year":"1997","unstructured":"Kudva YC, Hiddinga HJ, Butler PC, Mueske CS, Eberhardt NL (1997) Small heat shock proteins inhibit in vitro A beta(1-42) amyloidogenesis. FEBS Lett 416:117\u2013121","journal-title":"FEBS Lett"},{"key":"2340_CR128","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.bpj.2011.07.056","volume":"101","author":"SL Shammas","year":"2011","unstructured":"Shammas SL, Waudby CA, Wang S, Buell AK, Knowles TP, Ecroyd H, Welland ME, Carver JA, Dobson CM, Meehan S (2011) Binding of the molecular chaperone alphaB-crystallin to Abeta amyloid fibrils inhibits fibril elongation. Biophys J 101:1681\u20131689","journal-title":"Biophys J"},{"key":"2340_CR129","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1111\/j.1742-4658.2007.06144.x","volume":"274","author":"A Rekas","year":"2007","unstructured":"Rekas A, Jankova L, Thorn DC, Cappai R, Carver JA (2007) Monitoring the prevention of amyloid fibril formation by alpha-crystallin. Temperature dependence and the nature of the aggregating species. FEBS J 274:6290\u20136304","journal-title":"FEBS J"},{"key":"2340_CR130","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1002\/prot.23152","volume":"79","author":"IB Bruinsma","year":"2011","unstructured":"Bruinsma IB, Bruggink KA, Kinast K, Versleijen AA, Segers-Nolten IM, Subramaniam V, Kuiperij HB, Boelens W, de Waal RM, Verbeek MM (2011) Inhibition of alpha-synuclein aggregation by small heat shock proteins. Proteins 79:2956\u20132967","journal-title":"Proteins"},{"key":"2340_CR131","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.neurobiolaging.2006.11.009","volume":"29","author":"J Wang","year":"2008","unstructured":"Wang J, Martin E, Gonzales V, Borchelt DR, Lee MK (2008) Differential regulation of small heat shock proteins in transgenic mouse models of neurodegenerative diseases. Neurobiol Aging 29:586\u2013597","journal-title":"Neurobiol Aging"},{"key":"2340_CR132","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1128\/JB.180.19.5165-5172.1998","volume":"180","author":"JG Thomas","year":"1998","unstructured":"Thomas JG, Baneyx F (1998) Roles of the Escherichia coli small heat shock proteins IbpA and IbpB in thermal stress management: comparison with ClpA, ClpB, and HtpG in vivo. J Bacteriol 180:5165\u20135172","journal-title":"J Bacteriol"},{"key":"2340_CR133","doi-asserted-by":"crossref","first-page":"31033","DOI":"10.1074\/jbc.M303587200","volume":"278","author":"A Mogk","year":"2003","unstructured":"Mogk A, Schlieker C, Friedrich KL, Schonfeld HJ, Vierling E, Bukau B (2003) Refolding of substrates bound to small Hsps relies on a disaggregation reaction mediated most efficiently by ClpB\/DnaK. J Biol Chem 278:31033\u201331042","journal-title":"J Biol Chem"},{"key":"2340_CR134","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1099\/00221287-148-6-1757","volume":"148","author":"D Kuczynska-Wisnik","year":"2002","unstructured":"Kuczynska-Wisnik D, Kedzierska S, Matuszewska E, Lund P, Taylor A, Lipinska B, Laskowska E (2002) The Escherichia coli small heat-shock proteins IbpA and IbpB prevent the aggregation of endogenous proteins denatured in vivo during extreme heat shock. Microbiology 148:1757\u20131765","journal-title":"Microbiology"},{"key":"2340_CR135","doi-asserted-by":"crossref","first-page":"23869","DOI":"10.1074\/jbc.M502854200","volume":"280","author":"AG Cashikar","year":"2005","unstructured":"Cashikar AG, Duennwald M, Lindquist SL (2005) A chaperone pathway in protein disaggregation. Hsp26 alters the nature of protein aggregates to facilitate reactivation by Hsp104. J Biol Chem 280:23869\u201323875","journal-title":"J Biol Chem"},{"key":"2340_CR136","doi-asserted-by":"crossref","first-page":"23861","DOI":"10.1074\/jbc.M502697200","volume":"280","author":"M Haslbeck","year":"2005","unstructured":"Haslbeck M, Miess A, Stromer T, Walter S, Buchner J (2005) Disassembling protein aggregates in the yeast cytosol. The cooperation of Hsp26 with Ssa1 and Hsp104. J Biol Chem 280:23861\u201323868","journal-title":"J Biol Chem"},{"key":"2340_CR137","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/mt.sj.6300141","volume":"15","author":"V Perrin","year":"2007","unstructured":"Perrin V, Regulier E, Abbas-Terki T, Hassig R, Brouillet E, Aebischer P, Luthi-Carter R, Deglon N (2007) Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington\u2019s disease. Mol Ther 15:903\u2013911","journal-title":"Mol Ther"},{"key":"2340_CR138","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00018-014-1754-5","volume":"72","author":"TM Treweek","year":"2015","unstructured":"Treweek TM, Meehan S, Ecroyd H, Carver JA (2015) Small heat-shock proteins: important players in regulating cellular proteostasis. Cell Mol Life Sci 72:429\u2013451","journal-title":"Cell Mol Life Sci"},{"key":"2340_CR139","doi-asserted-by":"crossref","first-page":"E3780","DOI":"10.1073\/pnas.1308898110","volume":"110","author":"J Peschek","year":"2013","unstructured":"Peschek J, Braun N, Rohrberg J, Back KC, Kriehuber T, Kastenmuller A, Weinkauf S, Buchner J (2013) Regulated structural transitions unleash the chaperone activity of alphaB-crystallin. Proc Natl Acad Sci USA 110:E3780\u2013E3789","journal-title":"Proc Natl Acad Sci USA"},{"key":"2340_CR140","doi-asserted-by":"crossref","first-page":"37139","DOI":"10.1074\/jbc.M504106200","volume":"280","author":"J Engelsman den","year":"2005","unstructured":"den Engelsman J, Gerrits D, de Jong WW, Robbins J, Kato K, Boelens WC (2005) Nuclear import of {alpha}B-crystallin is phosphorylation-dependent and hampered by hyperphosphorylation of the myopathy-related mutant R120G. J Biol Chem 280:37139\u201337148","journal-title":"J Biol Chem"},{"issue":"1649\u20131660","key":"2340_CR141","first-page":"S1641","volume":"24","author":"S Hara","year":"2013","unstructured":"Hara S, Arawaka S, Sato H, Machiya Y, Cui C, Sasaki A, Koyama S, Kato T (2013) Serine 129 phosphorylation of membrane-associated alpha-synuclein modulates dopamine transporter function in a G protein-coupled receptor kinase-dependent manner. Mol Biol Cell 24(1649\u20131660):S1641\u2013S1643","journal-title":"Mol Biol Cell"},{"key":"2340_CR142","doi-asserted-by":"crossref","first-page":"12531","DOI":"10.1038\/srep12531","volume":"5","author":"SK Sharma","year":"2015","unstructured":"Sharma SK, Chorell E, Steneberg P, Vernersson-Lindahl E, Edlund H, Wittung-Stafshede P (2015) Insulin-degrading enzyme prevents alpha-synuclein fibril formation in a nonproteolytical manner. Sci Rep 5:12531","journal-title":"Sci Rep"},{"key":"2340_CR143","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2015.09.002","volume":"466","author":"SK Sharma","year":"2015","unstructured":"Sharma SK, Chorell E, Wittung-Stafshede P (2015) Insulin-degrading enzyme is activated by the C terminus of alpha-synuclein. Biochem Biophys Res Commun 466:192\u2013195","journal-title":"Biochem Biophys Res Commun"},{"key":"2340_CR144","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.molcel.2014.12.025","volume":"57","author":"ML Evans","year":"2015","unstructured":"Evans ML, Chorell E, Taylor JD, Aden J, Gotheson A, Li F, Koch M, Sefer L, Matthews SJ, Wittung-Stafshede P, Almqvist F, Chapman MR (2015) The bacterial curli system possesses a potent and selective inhibitor of amyloid formation. Mol Cell 57:445\u2013455","journal-title":"Mol Cell"},{"key":"2340_CR145","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1474-4422(15)00006-X","volume":"14","author":"B Dehay","year":"2015","unstructured":"Dehay B, Bourdenx M, Gorry P, Przedborski S, Vila M, Hunot S, Singleton A, Olanow CW, Merchant KM, Bezard E, Petsko GA, Meissner WG (2015) Targeting alpha-synuclein for treatment of Parkinson\u2019s disease: mechanistic and therapeutic considerations. Lancet Neurol 14:855\u2013866","journal-title":"Lancet Neurol"},{"key":"2340_CR146","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc1716","volume":"5","author":"L Whitesell","year":"2005","unstructured":"Whitesell L, Lindquist SL (2005) HSP90 and the chaperoning of cancer. Nat Rev Cancer 5:761\u2013772","journal-title":"Nat Rev Cancer"},{"key":"2340_CR147","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1196\/annals.1391.012","volume":"1113","author":"P Workman","year":"2007","unstructured":"Workman P, Burrows F, Neckers L, Rosen N (2007) Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress. Ann N Y Acad Sci 1113:202\u2013216","journal-title":"Ann N Y Acad Sci"},{"key":"2340_CR148","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cbpa.2007.05.035","volume":"11","author":"TD Butters","year":"2007","unstructured":"Butters TD (2007) Gaucher disease. Curr Opin Chem Biol 11:412\u2013418","journal-title":"Curr Opin Chem Biol"},{"key":"2340_CR149","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","volume":"372","author":"GA Grabowski","year":"2008","unstructured":"Grabowski GA (2008) Phenotype, diagnosis, and treatment of Gaucher\u2019s disease. Lancet 372:1263\u20131271","journal-title":"Lancet"},{"key":"2340_CR150","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa033277","volume":"351","author":"J Aharon-Peretz","year":"2004","unstructured":"Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R (2004) Mutations in the glucocerebrosidase gene and Parkinson\u2019s disease in Ashkenazi Jews. N Engl J Med 351:1972\u20131977","journal-title":"N Engl J Med"},{"key":"2340_CR151","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mgme.2001.3201","volume":"73","author":"N Tayebi","year":"2001","unstructured":"Tayebi N, Callahan M, Madike V, Stubblefield BK, Orvisky E, Krasnewich D, Fillano JJ, Sidransky E (2001) Gaucher disease and parkinsonism: a phenotypic and genotypic characterization. Mol Genet Metab 73:313\u2013321","journal-title":"Mol Genet Metab"},{"key":"2340_CR152","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/brain\/awt367","volume":"137","author":"KE Murphy","year":"2014","unstructured":"Murphy KE, Gysbers AM, Abbott SK, Tayebi N, Kim WS, Sidransky E, Cooper A, Garner B, Halliday GM (2014) Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson\u2019s disease. Brain 137:834\u2013848","journal-title":"Brain"},{"key":"2340_CR153","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/mds.26616","volume":"31","author":"AH Schapira","year":"2016","unstructured":"Schapira AH, Chiasserini D, Beccari T, Parnetti L (2016) Glucocerebrosidase in Parkinson\u2019s disease: insights into pathogenesis and prospects for treatment. Mov Disord 31:830\u2013835","journal-title":"Mov Disord"},{"key":"2340_CR154","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrneurol.2010.52","volume":"6","author":"AH Schapira","year":"2010","unstructured":"Schapira AH, Tolosa E (2010) Molecular and clinical prodrome of Parkinson disease: implications for treatment. Nat Rev Neurol 6:309\u2013317","journal-title":"Nat Rev Neurol"},{"key":"2340_CR155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mcn.2015.03.013","volume":"66","author":"AH Schapira","year":"2015","unstructured":"Schapira AH (2015) Glucocerebrosidase and Parkinson disease: recent advances. Mol Cell Neurosci 66:37\u201342","journal-title":"Mol Cell Neurosci"},{"key":"2340_CR156","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1073\/pnas.1424288112","volume":"112","author":"C Yang","year":"2015","unstructured":"Yang C, Wang H, Zhu D, Hong CS, Dmitriev P, Zhang C, Li Y, Ikejiri B, Brady RO, Zhuang Z (2015) Mutant glucocerebrosidase in Gaucher disease recruits Hsp27 to the Hsp90 chaperone complex for proteasomal degradation. Proc Natl Acad Sci USA 112:1137\u20131142","journal-title":"Proc Natl Acad Sci USA"},{"key":"2340_CR157","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/cmdc.201300327","volume":"8","author":"W Schonemann","year":"2013","unstructured":"Schonemann W, Gallienne E, Ikeda-Obatake K, Asano N, Nakagawa S, Kato A, Adachi I, Gorecki M, Frelek J, Martin OR (2013) Glucosylceramide mimics: highly potent GCase inhibitors and selective pharmacological chaperones for mutations associated with types 1 and 2 Gaucher disease. Chem Med Chem 8:1805\u20131817","journal-title":"Chem Med Chem"},{"key":"2340_CR158","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1021\/jm060677i","volume":"50","author":"Z Yu","year":"2007","unstructured":"Yu Z, Sawkar AR, Whalen LJ, Wong CH, Kelly JW (2007) Isofagomine- and 2,5-anhydro-2,5-imino-d-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention. J Med Chem 50:94\u2013100","journal-title":"J Med Chem"},{"key":"2340_CR159","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awu020","volume":"137","author":"A McNeill","year":"2014","unstructured":"McNeill A, Magalhaes J, Shen C, Chau KY, Hughes D, Mehta A, Foltynie T, Cooper JM, Abramov AY, Gegg M, Schapira AH (2014) Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells. Brain 137:1481\u20131495","journal-title":"Brain"},{"key":"2340_CR160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bcmd.2012.10.007","volume":"50","author":"I Bendikov-Bar","year":"2013","unstructured":"Bendikov-Bar I, Maor G, Filocamo M, Horowitz M (2013) Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase. Blood Cells Mol Dis 50:141\u2013145","journal-title":"Blood Cells Mol Dis"},{"key":"2340_CR161","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1038\/emboj.2008.194","volume":"27","author":"J Shorter","year":"2008","unstructured":"Shorter J, Lindquist S (2008) Hsp104, Hsp70 and Hsp40 interplay regulates formation, growth and elimination of Sup35 prions. EMBO J 27:2712\u20132724","journal-title":"EMBO J"},{"key":"2340_CR162","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.bbadis.2014.06.024","volume":"1842","author":"D Cox","year":"2014","unstructured":"Cox D, Carver JA, Ecroyd H (2014) Preventing alpha-synuclein aggregation: the role of the small heat-shock molecular chaperone proteins. Biochim Biophys Acta 1842:1830\u20131843","journal-title":"Biochim Biophys Acta"},{"key":"2340_CR163","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/19336896.2015.1020277","volume":"9","author":"ME Jackrel","year":"2015","unstructured":"Jackrel ME, Shorter J (2015) Engineering enhanced protein disaggregases for neurodegenerative disease. Prion 9:90\u2013109","journal-title":"Prion"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2340-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-016-2340-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2340-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2340-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T04:50:21Z","timestamp":1601009421000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-016-2340-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,13]]},"references-count":163,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["2340"],"URL":"https:\/\/doi.org\/10.1007\/s00018-016-2340-9","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,13]]}}}